“Immunogenicity and Safety of Cervarix HPV-16 18 AS04-Adjuvant Vaccine Against HPV Induced Cervical Cancer in Women (15+ Years)”. 2024. UCC Student Medical Journal 3 (October): 50-61. https://doi.org/10.33178/SMJ.2023.1.5.